Overview
Wesam Ahmed is a Hematologist in Nashville, Tennessee. Dr. Ahmed has been practicing medicine for over 29 years and is rated as an Experienced provider by MediFind in the treatment of B-Cell Lymphoma. His top areas of expertise are Acute Megakaryoblastic Leukemia, Childhood Acute Myeloid Leukemia, Acute Myeloid Leukemia (AML), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Ahmed is currently accepting new patients.
His clinical research consists of co-authoring 10 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of B-Cell Lymphoma.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Tennessee Oncology PLLC
Ian Flinn is a Hematologist Oncology specialist and a Hematologist in Tullahoma, Tennessee. Dr. Flinn is rated as an Elite provider by MediFind in the treatment of B-Cell Lymphoma. His top areas of expertise are Small Lymphocytic Lymphoma (SLL), Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Flinn is currently accepting new patients.
Gilbert Barbee Moore And Mcilvoy Psc
Vidya Seshadri is a Hematologist and an Oncologist in Bowling Green, Kentucky. Dr. Seshadri is rated as a Distinguished provider by MediFind in the treatment of B-Cell Lymphoma. Her top areas of expertise are Inflammatory Breast Cancer, Angiosarcoma, Familial Colorectal Cancer, and Lung Cancer.
Sarah Cannon Research Institute
Dr. Patel joined SCRI in 2024, as director of lymphoma research, and oversees SCRI’s comprehensive lymphoma clinical trial portfolio. Previously, he served as the Director of Hematologic Malignancies and Cell Therapy at the Swedish Cancer Institute in Seattle, Washington, where he led development of the program’s clinical standards for lymphoma care, assisted in the expansion of cell therapy services, and helped shape lymphoma research efforts. Dr. Patel was also a member of the Paul G. Allen Research Center at Seattle Cancer Institute, serving as a co-founding member of the Center for Immuno-oncology, where he collaborated on translational research related to immunotherapy in hematologic diseases.Dr. Patel has been published in various medical journals, including New England Journal of Medicine, Blood, and Journal of Clinical Oncology. He is also a member of the ASCO Cancer Communications Committee, the CIBMTR Lymphoma Working Committee, and the National Planning Committee for the Lymphoma Research Foundation Lymphoma Rounds. His clinical and research focus is in lymphomas, CLL, and cellular therapy. Dr. Patel is rated as a Distinguished provider by MediFind in the treatment of B-Cell Lymphoma. His top areas of expertise are Follicular Lymphoma, Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Transplant, and Bone Marrow Aspiration.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Ahmed isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Megakaryoblastic LeukemiaDr. Ahmed isExperienced. Learn about Acute Megakaryoblastic Leukemia.
- Acute Monoblastic Leukemia (AmoL)Dr. Ahmed isExperienced. Learn about Acute Monoblastic Leukemia (AmoL).
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Ahmed isExperienced. Learn about Acute Myeloid Leukemia (AML).